Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-11-18 | Amended | $12,189,298 | $1,437,437 | Equity Only | 06b | SEC link |
| 2024-09-12 | New | $10,751,861 | $10,751,861 | Equity Only | 06b | SEC link |
| 2024-04-24 | Amended | $3,409,306 | $795,000 | Debt Only | 06b | SEC link |
| 2023-10-19 | Amended | $2,614,306 | $788,699 | Debt Only | 06b | SEC link |
| 2023-03-29 | Amended | $1,825,607 | $827,000 | Debt Only | 06b | SEC link |
| 2022-09-08 | New | $998,607 | $998,607 | Debt Only | 06b | SEC link |
| 2021-12-17 | Amended | $427,500 | $300,000 | Debt Only | 06b | SEC link |
| 2021-10-25 | New | $127,500 | $127,500 | Debt Only | 06b | SEC link |
| Name | Role |
|---|---|
| Elsa Abruzzo | Director, Executive |
| Pj Anand | Director |
| Darryl Baker | Executive |
| David Donabedian | Director |
| Edgar D Janotta | Director |
| Ghassan Kassab | Director |
| Stephen Oesterle | Director |
| Stanton Rowe | Director |
| Natalie Stevens | Executive |
| Richard Upton | Director |